AU2006319244B2 - Serotonin transporter (SERT) inhibitors - Google Patents
Serotonin transporter (SERT) inhibitors Download PDFInfo
- Publication number
- AU2006319244B2 AU2006319244B2 AU2006319244A AU2006319244A AU2006319244B2 AU 2006319244 B2 AU2006319244 B2 AU 2006319244B2 AU 2006319244 A AU2006319244 A AU 2006319244A AU 2006319244 A AU2006319244 A AU 2006319244A AU 2006319244 B2 AU2006319244 B2 AU 2006319244B2
- Authority
- AU
- Australia
- Prior art keywords
- phenyl
- pyrrolidine
- benzyloxymethyl
- trifluoromethyl
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05111565 | 2005-12-01 | ||
| EP05111565.7 | 2005-12-01 | ||
| PCT/EP2006/068740 WO2007063009A1 (en) | 2005-12-01 | 2006-11-22 | Serotonin transporter (sert) inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2006319244A1 AU2006319244A1 (en) | 2007-06-07 |
| AU2006319244B2 true AU2006319244B2 (en) | 2011-07-07 |
Family
ID=37686112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2006319244A Ceased AU2006319244B2 (en) | 2005-12-01 | 2006-11-22 | Serotonin transporter (SERT) inhibitors |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20070129419A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1957450B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5020967B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101091376B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101316816B (cg-RX-API-DMAC7.html) |
| AT (1) | ATE434605T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006319244B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0619154A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2631221C (cg-RX-API-DMAC7.html) |
| DE (1) | DE602006007483D1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2326285T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL191468A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007063009A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012051103A1 (en) | 2010-10-11 | 2012-04-19 | Theravance, Inc. | Serotonin reuptake inhibitors |
| WO2014152768A1 (en) * | 2013-03-15 | 2014-09-25 | Portola Pharmaceuticals, Inc. | Cyclohexanediamine compounds and methods for their preparation |
| CN106459013B (zh) | 2014-05-15 | 2019-10-25 | 阵列生物制药公司 | 作为trka激酶抑制剂的化合物及其用途 |
| MA43313B1 (fr) | 2015-09-02 | 2022-06-30 | Trevena Inc | Aza-hétérocyclique à 6 éléments contenant des composés modulateurs de récepteurs opioïdes delta, et leurs procédés de fabrication et d'utilisation |
| CN110520129A (zh) * | 2017-02-17 | 2019-11-29 | 特维娜有限公司 | 含有5元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法 |
| CN110446495B (zh) | 2017-02-17 | 2023-09-05 | 特维娜有限公司 | 含有7元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法 |
| US20220213061A9 (en) * | 2020-02-25 | 2022-07-07 | Tes Pharma S.R.L. | Heterocyclic compounds for modulating nr2f6 |
| CN116406268A (zh) | 2020-10-27 | 2023-07-07 | 特维娜有限公司 | δ-阿片样物质调节剂的结晶和无定形形式 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005032464A2 (en) * | 2003-09-30 | 2005-04-14 | Merck & Co., Inc. | Phenyl pyrrolidine ether tachykinin receptor antagonists |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI94339C (fi) * | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
| GB0119797D0 (en) * | 2001-08-14 | 2001-10-03 | Glaxo Group Ltd | Chemical compounds |
| EP1451153B1 (en) * | 2001-11-13 | 2007-09-26 | Schering Corporation | Nk1 antagonists |
| US7138423B2 (en) * | 2004-07-20 | 2006-11-21 | Bristol-Myers Squibb Company | Arylpyrrolidine derivatives as NK-1 /SSRI antagonists |
-
2006
- 2006-11-22 CA CA2631221A patent/CA2631221C/en not_active Expired - Fee Related
- 2006-11-22 KR KR1020087013216A patent/KR101091376B1/ko not_active Expired - Fee Related
- 2006-11-22 BR BRPI0619154-1A patent/BRPI0619154A2/pt not_active IP Right Cessation
- 2006-11-22 ES ES06819656T patent/ES2326285T3/es active Active
- 2006-11-22 JP JP2008542719A patent/JP5020967B2/ja not_active Expired - Fee Related
- 2006-11-22 DE DE602006007483T patent/DE602006007483D1/de active Active
- 2006-11-22 CN CN2006800444805A patent/CN101316816B/zh not_active Expired - Fee Related
- 2006-11-22 US US11/603,515 patent/US20070129419A1/en not_active Abandoned
- 2006-11-22 AT AT06819656T patent/ATE434605T1/de active
- 2006-11-22 AU AU2006319244A patent/AU2006319244B2/en not_active Ceased
- 2006-11-22 WO PCT/EP2006/068740 patent/WO2007063009A1/en not_active Ceased
- 2006-11-22 EP EP06819656A patent/EP1957450B1/en not_active Not-in-force
-
2008
- 2008-05-15 IL IL191468A patent/IL191468A/en not_active IP Right Cessation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005032464A2 (en) * | 2003-09-30 | 2005-04-14 | Merck & Co., Inc. | Phenyl pyrrolidine ether tachykinin receptor antagonists |
Also Published As
| Publication number | Publication date |
|---|---|
| IL191468A (en) | 2012-02-29 |
| DE602006007483D1 (cg-RX-API-DMAC7.html) | 2009-08-06 |
| EP1957450A1 (en) | 2008-08-20 |
| KR20080064200A (ko) | 2008-07-08 |
| JP2009517435A (ja) | 2009-04-30 |
| EP1957450B1 (en) | 2009-06-24 |
| US20070129419A1 (en) | 2007-06-07 |
| KR101091376B1 (ko) | 2011-12-07 |
| JP5020967B2 (ja) | 2012-09-05 |
| AU2006319244A1 (en) | 2007-06-07 |
| CN101316816B (zh) | 2011-07-27 |
| CA2631221A1 (en) | 2007-06-07 |
| ATE434605T1 (de) | 2009-07-15 |
| BRPI0619154A2 (pt) | 2011-09-20 |
| ES2326285T3 (es) | 2009-10-06 |
| WO2007063009A1 (en) | 2007-06-07 |
| CA2631221C (en) | 2014-06-03 |
| CN101316816A (zh) | 2008-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2682506C (en) | Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists | |
| IL191468A (en) | Serotonin transporter (sert) inhibitors, process for their preparation, medicaments containing them and use thereof in the preparation of medicaments for the treatment of anxiety and depression | |
| AU2004247487B2 (en) | N-pyrrolidin-3-YL-amide derivatives as serotonin and noradrenaline re-uptake inhibitors | |
| IL174936A (en) | Derivatives of n-[phenyl(alkylpiperidine-2- yl) methyl] benzamide, medicaments and pharmaceutical compositions comprising them and their use in the preparation of medicaments | |
| US7528136B2 (en) | Prolinamide derivatives as NK3 antagonists | |
| IL174934A (en) | Derivatives of n - [phenyl(2-pyrrolidinyl) methyl] benzamide and n - [phenyl (2 - azepanyl) methyl] benzamide, medicament thereof, pharmaceutical composition thereof and use thereof in the preparation of a medicament | |
| EP2364295B1 (en) | 3-(benzylamino)-pyrrolidine derivatives and their use as nk-3 receptor antagonists | |
| CA2648065C (en) | Piperidine derivatives useful as serotonin transporter inhibitors and neurokinin-1 receptor antagonists | |
| US7501422B2 (en) | Prolinamide-tetrazole derivatives as NK3 receptor antagonists | |
| WO2005068447A1 (en) | Piperazine derivatives which exhibit activity as serotonin and noradrenaline re-upatke inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |